At the 37th Annual Transcatheter Cardiovascular Therapeutics (TCT 2025) symposium in San Francisco, researchers from Zhongshan Hospital affiliated with Fudan University presented groundbreaking findings on China’s independently developed PANVIS STAR Vascular Interventional Surgery Control System. The multicenter randomized controlled trial demonstrated that the robotic system ensures safety, efficiency, and reduced radiation exposure in PCI procedures – a leap forward in interventional cardiology.
A Solution to Physicians’ Occupational Risks
Traditional PCI procedures expose physicians to significant occupational hazards, including radiation and orthopedic strain. PANVIS STAR addresses these challenges by integrating intuitive, ergonomic design and AI-powered robotic assistance, allowing interventionalists to operate safely and efficiently, even remotely, without compromising precision or control.
Design Innovation and Advanced Capabilities
Developed by Shenzhen Institute of Advanced Biomedical Robot Co., Ltd. (abrobo), PANVIS STAR features several pioneering elements:
- PANVIS COF (Catheter On Finger) intuitive operating system that replicates manual movement.
- Dual-device support via a sterile cassette design, increasing flexibility for complex lesions.
- Ultra-long travel and 5G-enabled remote operation, offering pan-vascular compatibility and the potential for long-distance procedures.
Clinical Findings: Safety and Performance Validated
The CAPTAIN-C study, led by Academician Ge Junbo, evaluated 144 PCI cases across multiple centers. Results showed:
- Clinical success rate: 97.18% in robotic procedures.
- Technical success rate: 100%, with no manual conversions.
- Radiation exposure reduction: 97.2% for operating physicians.
The findings confirmed the robot’s operational stability and its ability to handle complex coronary cases while ensuring patient safety and procedural success.
Pioneering Remote Surgery and Future Expansion
In a landmark demonstration, the team successfully performed a 5,200 km remote PCI using the PANVIS STAR system, connecting specialists in Shanghai and Xinjiang. This breakthrough sets the stage for a new era of cross-hospital and cross-regional tele-interventions, expanding access to advanced cardiovascular care worldwide.
Redefining Precision and Accessibility in Cardiology
The PANVIS STAR’s success highlights China’s growing capabilities in independent R&D and clinical translation of interventional robotics. As AI and 5G integration deepen, the technology is expected to evolve toward intelligent navigation, automated procedural planning, and collaborative remote operations, reshaping the global landscape of cardiovascular medicine.
Share your Details for subscribe